Author name: Claritas Rx

Medication Adherence Technology

How Emerging Technology is Transforming Medication Adherence

The Challenge of Medication Non-Adherence in Specialty Pharmacy Medication adherence refers to whether patients take their medications as prescribed, including the correct dose, at the correct times, and for the prescribed duration. It is a crucial aspect of managing chronic conditions and maintaining overall health. Despite its importance, medication non-adherence is a significant issue. It […]

How Emerging Technology is Transforming Medication Adherence Read More »

GSK and Flagship Pioneering Partnership

Power of Biopharma Partnerships: GSK and Flagship Pioneering

Introduction In the fast-paced world of biopharma, partnerships can drive remarkable advancements. GlaxoSmithKline (GSK), a global healthcare leader, is taking a bold step by teaming up with Flagship Pioneering, a trailblazer in venture creation and life sciences innovation. This collaboration aims to develop up to 10 new vaccines and pharmaceuticals, initially focusing on the respiratory

Power of Biopharma Partnerships: GSK and Flagship Pioneering Read More »

Donanemab, Alzheimer's drug

Eli Lilly’s Urgent Push for Alzheimer’s Treatment Revolution

Introduction In the tough terrain of finding an Alzheimer’s cure, Eli Lilly is setting the pace with their latest innovation – the FDA-approved drug, Donanemab, commercially known as Kisunla. This blog delves into Lilly’s strategic maneuvers to expedite sales and cultivate urgent demand within the pharmaceutical sector. The vast population of patients combined with a

Eli Lilly’s Urgent Push for Alzheimer’s Treatment Revolution Read More »

pfizer glp-1 drug developmemt

Pfizer’s Bold Move in the Obesity Drug Market

Within a sector populated by many market pioneers promoting injectable solutions, Pfizer is redefining the landscape with an oral medication for obesity. This article explores Pfizer‘s strategic moves towards securing a prominent position in the obesity treatment market, focusing especially on their groundbreaking work on a GLP-1 drug. Introduction Pfizer, a titan in the pharmaceutical

Pfizer’s Bold Move in the Obesity Drug Market Read More »

competitive insights

Unlocking Competitive Data Insights in Therapy Basket Fill Rates

In the biopharma industry, understanding how your therapy basket’s fill rate stacks up against competitors can be a game-changer. This blog post dives deep into the significance of therapy basket fill rates, providing exclusive data insights and practical tips to help biopharma executives stay ahead in the competitive landscape. The Importance of Therapy Basket Fill

Unlocking Competitive Data Insights in Therapy Basket Fill Rates Read More »

calquence mcl

AstraZeneca’s Calquence Sets New Standard for Lymphoma

Mantle cell lymphoma (MCL) is a rare yet aggressive form of non-Hodgkin lymphoma, and treatment options have been limited for far too long. For pharmaceutical professionals and biopharma executives, staying at the forefront of treatment innovations is crucial. Recently, AstraZeneca has made significant strides with its BTK inhibitor, Calquence, challenging the current standard of care

AstraZeneca’s Calquence Sets New Standard for Lymphoma Read More »

fda guide

FDA Draft Guidance: Fast-Track Cell and Gene Therapies

The FDA unveiled a much-anticipated draft guide, outlining how businesses can secure approvals for platform technologies. This regulatory advance has the potential to fast-track the FDA’s ‘platform technology’ procedure, potentially accelerating the endorsement of cell and gene therapies. Keen to find out more? This comprehensive 15-page draft guide provides a wealth of knowledge for biopharma

FDA Draft Guidance: Fast-Track Cell and Gene Therapies Read More »